FOENIX-101: a phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements
dc.contributor.author | Goyal, L | |
dc.contributor.author | Bahleda, R | |
dc.contributor.author | Furuse, J | |
dc.contributor.author | Valle, Juan W | |
dc.contributor.author | Moehler, MH | |
dc.contributor.author | Oh, DY | |
dc.contributor.author | Chang, HM | |
dc.contributor.author | Kelley, RK | |
dc.contributor.author | Javle, MM | |
dc.contributor.author | Borad, MJ | |
dc.contributor.author | Chen, LT | |
dc.contributor.author | Uboha, NV | |
dc.contributor.author | Klumpen, HJ | |
dc.contributor.author | O'Dwyer, PJ | |
dc.contributor.author | Li, DN | |
dc.contributor.author | Morizane, C | |
dc.contributor.author | Huang, J | |
dc.contributor.author | Bridgewater, JA | |
dc.date.accessioned | 2019-11-19T16:01:10Z | |
dc.date.available | 2019-11-19T16:01:10Z | |
dc.date.issued | 2019 | en |
dc.identifier.citation | Goyal L, Bahleda R, Furuse J, Valle JW, Moehler MH, Oh D-Y, et al. FOENIX-101: a phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements. J Clin Oncol. 2019;37(4_suppl):TPS468-TPS. | en |
dc.identifier.doi | 10.1200/JCO.2019.37.4_suppl.TPS468 | en |
dc.identifier.uri | http://hdl.handle.net/10541/622481 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1200/JCO.2019.37.4_suppl.TPS468 | en |
dc.title | FOENIX-101: a phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Massachusetts General Hospital, Boston, MA | en |
dc.identifier.journal | Journal of Clinical Oncology | en |